Reclassification
FDA may reclassify a device type — moving it from a higher class to a lower class (downclassification) or from a lower to a higher class (upclassification) — as scientific and regulatory understanding evolves.
Types of reclassification
Downclassification (Class III → Class II or I)
FDA may downclassify a device type when it determines that general controls and/or special controls are sufficient to provide reasonable assurance of safety and effectiveness — and PMA-level evidence is no longer necessary.
Downclassification opens the pathway for 510(k) clearance for a device type that previously required PMA.
Upclassification (Class I or II → Class III)
If FDA determines that a device type poses greater risks than previously recognised, it may upclassify it and require PMA for future devices of that type. Manufacturers of existing legally marketed devices must submit PMAs or cease marketing.
How reclassification happens
Manufacturer petition (21 CFR § 860.132)
A manufacturer may petition FDA to reclassify a device type. The petition must:
- Identify the device type and current classification
- Propose a new classification
- Provide valid scientific evidence supporting the proposed classification
- Propose special controls (if downclassifying to Class II)
FDA publishes a proposed order in the Federal Register, solicits public comment, and issues a final order.
FDA-initiated reclassification
FDA may initiate reclassification on its own initiative based on post-market data, new scientific evidence, or public health considerations.
De Novo as a downclassification mechanism
When a De Novo request is granted for a novel device, FDA effectively creates a new Class II (or Class I) type — this is a form of classification that may then serve as the predicate for future 510(k)s.
Impact on existing devices
When a device type is downclassified:
- Devices approved under PMA may continue to be marketed under the existing PMA
- New devices of that type may seek 510(k) clearance
When a device type is upclassified:
- Existing PMA-exempt devices receive a transition period to submit PMAs
- New devices of that type require PMA immediately